BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7792804)

  • 1. Familial pseudohypoaldosteronism: a review on the heterogeneity of the syndrome.
    Kuhnle U; Hinkel GK; Akkurt HI; Krozowski Z
    Steroids; 1995 Jan; 60(1):157-60. PubMed ID: 7792804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system.
    Kuhnle U; Hinkel GK; Hubl W; Reichelt T
    Horm Res; 1996; 46(3):124-9. PubMed ID: 8894667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescence of mineralocorticoid receptors in peripheral lymphocytes: presence of receptor-like activity in patients with the autosomal dominant form of pseudohypoaldosteronism, and its absence in the recessive form.
    Kuhnle U; Keller U; Armanini D; Funder J; Krozowski Z
    J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):267-73. PubMed ID: 7826888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects.
    Kuhnle U; Nielsen MD; Tietze HU; Schroeter CH; Schlamp D; Bosson D; Knorr D; Armanini D
    J Clin Endocrinol Metab; 1990 Mar; 70(3):638-41. PubMed ID: 2137831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudohypoaldosteronism and mineralocorticoid receptor abnormalities.
    Armanini D; Wehling M; Da Dalt L; Zennaro M; Scali U; Keller U; Pratesi C; Mantero F; Kuhnle U
    J Steroid Biochem Mol Biol; 1991; 40(1-3):363-5. PubMed ID: 1659876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
    Fernandes-Rosa FL; Antonini SR
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.
    Viemann M; Peter M; López-Siguero JP; Simic-Schleicher G; Sippell WG
    J Clin Endocrinol Metab; 2001 May; 86(5):2056-9. PubMed ID: 11344206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
    Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
    Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
    Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).
    Nyström AM; Bondeson ML; Skanke N; Mårtensson J; Strömberg B; Gustafsson J; Annerén G
    J Clin Endocrinol Metab; 2004 Jan; 89(1):227-31. PubMed ID: 14715854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of amiloride-sensitive sodium channel subunits in five sporadic cases of pseudohypoaldosteronism: do they have pathologic potential?
    Arai K; Zachman K; Shibasaki T; Chrousos GP
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2434-7. PubMed ID: 10404817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inheritance of mineralocorticoid effector abnormalities of human mononuclear leucocytes in families with pseudohypoaldosteronism.
    Wehling M; Kuhnle U; Daumer C; Armanini D
    Clin Endocrinol (Oxf); 1989 Nov; 31(5):597-605. PubMed ID: 2627754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
    Escoubet B; Couffignal C; Laisy JP; Mangin L; Chillon S; Laouénan C; Serfaty JM; Jeunemaitre X; Mentré F; Zennaro MC
    Circ Cardiovasc Genet; 2013 Aug; 6(4):381-90. PubMed ID: 23852419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-aldosterone system evaluation over four decades in an extended family with autosomal dominant pseudohypoaldosteronism due to a deletion in the NR3C2 gene.
    Hanukoglu A; Vargas-Poussou R; Landau Z; Yosovich K; Hureaux M; Zennaro MC
    J Steroid Biochem Mol Biol; 2020 Nov; 204():105755. PubMed ID: 33017655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of renal pseudohypoaldosteronism type 1.
    Riepe FG
    Expert Rev Endocrinol Metab; 2007 May; 2(3):407-419. PubMed ID: 30743803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.
    Sartorato P; Lapeyraque AL; Armanini D; Kuhnle U; Khaldi Y; Salomon R; Abadie V; Di Battista E; Naselli A; Racine A; Bosio M; Caprio M; Poulet-Young V; Chabrolle JP; Niaudet P; De Gennes C; Lecornec MH; Poisson E; Fusco AM; Loli P; Lombès M; Zennaro MC
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2508-17. PubMed ID: 12788847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.
    Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.